Q BioMed Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2017 - 2014
Period Ending	Oct '24 Oct 17, 2024	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018	2017 - 2014
Market Capitalization	0	1	13	26	27	28	Upgrade
Market Cap Growth	-81.89%	-89.57%	-49.78%	-3.74%	-3.66%	-47.12%	Upgrade
Enterprise Value	9	10	20	32	31	27	Upgrade
Last Close Price	0.00	0.02	0.45	1.10	1.60	1.95	Upgrade
PE Ratio	-	-0.20	-1.37	-1.70	-2.34	-2.89	Upgrade
PS Ratio	0.00	4.74	66.12	858.39	-	-	Upgrade
PB Ratio	-0.27	-0.29	-2.76	-23.94	-5.30	-262.64	Upgrade
P/FCF Ratio	0.79	0.69	-3.01	-4.13	-6.52	-4.30	Upgrade
P/OCF Ratio	0.79	0.69	-3.01	-4.13	-6.52	-4.30	Upgrade
EV/Sales Ratio	44.20	36.01	102.50	1057.67	-	-	Upgrade
EV/EBITDA Ratio	-3.97	-3.02	-2.73	-2.42	-3.90	-	Upgrade
EV/EBIT Ratio	-3.90	-2.97	-2.71	-2.41	-3.88	-2.99	Upgrade
EV/FCF Ratio	4.87	5.27	-4.66	-5.09	-7.58	-4.18	Upgrade
Debt / Equity Ratio	-0.63	-0.89	-0.65	-0.09	-0.73	-27.18	Upgrade
Debt / FCF Ratio	1.87	2.12	-0.71	-0.01	-0.90	-0.45	Upgrade
Asset Turnover	0.10	0.13	0.27	0.05	-	-	Upgrade
Quick Ratio	0.00	0.01	0.08	0.10	0.03	6.25	Upgrade
Current Ratio	0.00	0.01	0.08	0.13	0.04	6.28	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-7401.35%	Upgrade
Return on Assets (ROA)	-85.13%	-99.58%	-644.52%	-1300.21%	-261.26%	-280.17%	Upgrade
Return on Capital (ROIC)	-	-	-	-	-709.57%	-360.93%	Upgrade
Earnings Yield	-3091800.00%	-152.09%	-63.72%	-52.39%	-38.42%	-33.39%	Upgrade
FCF Yield	126.08%	143.89%	-33.27%	-24.21%	-15.34%	-23.23%	Upgrade
Buyback Yield / Dilution	-130.36%	-67.13%	-20.84%	-47.34%	-9.50%	-31.23%	Upgrade
Total Shareholder Return	-130.36%	-67.13%	-20.84%	-47.34%	-9.50%	-31.23%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.